Photodynamic therapy plus root debridement in gum disease treatment V2

  • Research type

    Research Study

  • Full title

    A split-mouth randomised controlled clinical trial of photodynamic therapy (PDT) as adjunctive therapy to root surface debridement (RSD), compared to RSD alone in the treatment of residual periodontal pockets in patients with chronic periodontitis

  • IRAS ID

    210535

  • Contact name

    Gareth S Griffiths

  • Contact email

    g.s.griffiths@sheffield.ac.uk

  • Sponsor organisation

    Sheffield Teaching Hospitals NHS Foundation Trust

  • Duration of Study in the UK

    0 years, 9 months, 31 days

  • Research summary

    Gum disease is a common disease, which affects 45% of the UK adult dentate population. It is caused by bacteria in dental plaque, which produces inflammation and a deepening of the natural crevice between the gum and the tooth surface. A crevice of 3mm is considered to be within the normal range, but anything ≥4mm is considered to be abnormal and is called a “pocket”.

    Standard treatment of gum disease is mechanical cleaning aimed at removing bacteria off the root surfaces of the teeth. For most teeth, in the majority of patients, this can be achieved by root surface debridement (RSD), which involves passing instruments into the gum pockets to clean the roots. Previous studies have shown that the outcome of treatment is less effective when the pockets are deeper, or where there is bone or root anatomy which makes access for RSD difficult. In such instances additional approaches, such as repeating RSD, surgical access, or the additional use of antibiotics are considered.

    This clinical study will investigate the benefits and drawbacks of using a light source and dye (photodynamic therapy – PDT) as an additional treatment compared to the standard treatment of RSD alone. Patients with chronic gum problems who have undergone 1 cycle of RSD, but have residual pockets will be invited to join the study. All residual pockets will be treated with the conventional treatment of RSD. Following a random allocation process the residual pockets in half the mouth will receive additional treatment with PDT at the same appointment. Patients will be followed up for 3 months to evaluate the clinical benefits and any side effects.

    The aim of the study is therefore to evaluate if this localised, simple treatment can add benefit to RSD alone, thus reducing the need for antibiotics or surgery to treat residual pockets.

  • REC name

    Yorkshire & The Humber - South Yorkshire Research Ethics Committee

  • REC reference

    17/YH/0213

  • Date of REC Opinion

    8 Aug 2017

  • REC opinion

    Further Information Favourable Opinion